Vaxart (VXRT) director reports open-market purchase of 20,000 shares at about $0.41

Q: What insider transaction did Vaxart (VXRT) disclose in this Form 4?

The filing shows a Vaxart director purchased 15,000 shares of common stock at $0.41 per share and 5,000 shares at $0.407 per share on 11/17/2025 .

Q: What transaction code was used for the Vaxart (VXRT) insider trades?

The transactions are reported with code P , indicating open-market or private purchase of Vaxart common stock.

Q: On what date were the Vaxart (VXRT) insider purchases executed?

The purchases of Vaxart common stock were executed on 11/17/2025 .

Q: What is the relationship of the reporting person to Vaxart (VXRT)?

The reporting person is identified as a Director of Vaxart, Inc.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Vaxart, Inc. director reports open-market stock purchases. A Vaxart (VXRT) director bought 15,000 shares of common stock on 11/17/2025 at a price of $0.41 per share and an additional 5,000 shares at $0.407 per share, both coded as open-market purchases. Following these transactions, the director beneficially owns 124,125 shares of Vaxart common stock in direct ownership form. The report notes that the filing was submitted late due to delays in receiving EDGAR access codes.

Insider Trade Summary

Net Buyer: 20,000 shares

Net Buy 2 txns

Insider Watson W. Mark

Role Director

Bought 20,000 shs ($8K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	15,000	$0.41	$6K
Purchase	Common Stock	5,000	$0.407	$2K

Holdings After Transaction: Common Stock — 124,125 shares (Direct)

Footnotes (1)

F1. This Form 4 is being filed late due to delays in receiving EDGAR access codes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/05/2025 - 05:46 PM

FAQ

What insider transaction did Vaxart (VXRT) disclose in this Form 4?

The filing shows a Vaxart director purchased 15,000 shares of common stock at $0.41 per share and 5,000 shares at $0.407 per share on 11/17/2025.

How many Vaxart (VXRT) shares does the reporting person own after the transaction?

After the reported purchases, the director beneficially owns 124,125 shares of Vaxart common stock in direct ownership.

What transaction code was used for the Vaxart (VXRT) insider trades?

The transactions are reported with code P, indicating open-market or private purchase of Vaxart common stock.

On what date were the Vaxart (VXRT) insider purchases executed?

The purchases of Vaxart common stock were executed on 11/17/2025.

Why was this Vaxart (VXRT) Form 4 filed late?

The explanation states that the form is being filed late due to delays in receiving EDGAR access codes.

What is the relationship of the reporting person to Vaxart (VXRT)?

The reporting person is identified as a Director of Vaxart, Inc.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Watson W. Mark

(Last)

(First)

(Middle)

C/O VAXART, INC.

170 HARBOR WAY, SUITE 300

(Street)

SOUTH SAN FRANCISCO

94080

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Vaxart, Inc. [ VXRT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/17/2025⁽¹⁾		P		15,000	A	$0.41	119,125	D
Common Stock	11/17/2025⁽¹⁾		P		5,000	A	$0.407	124,125	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This Form 4 is being filed late due to delays in receiving EDGAR access codes.

	/s/ Edward Berg, Attorney-in-Fact for W. Mark Watson	12/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR